Keyphrases
Basal Ganglia
100%
Transgenic
100%
Metabolic Changes
100%
Huntington's Disease
100%
Electrophysiological Changes
100%
Subthalamic nucleus
83%
Globus Pallidus
66%
Therapeutic Intervention
33%
Surgical Therapy
33%
Neuronal Activity
33%
Striatum
33%
Metabolic Activity
33%
Firing Frequency
33%
Peroxisome Proliferator-activated Receptor-γ coactivator-1α (PGC-1α)
33%
Electrical Activity
16%
Basal Ganglia Circuits
16%
Deep Brain Stimulation
16%
Immunohistochemistry
16%
Motor Symptoms
16%
Substantia Nigra
16%
Electrophysiological Recordings
16%
Neurobiology
16%
Littermate
16%
Peroxisome Proliferator-activated Receptor
16%
Cell Behavior
16%
Neuronal Loss
16%
Transcriptional Repressor
16%
Transgenic Mouse Model
16%
Optical Density
16%
Cytochrome Oxidase Histochemistry
16%
Neuronal Mapping
16%
Metabolic Mapping
16%
Entopeduncular nucleus
16%
Ablative Surgery
16%
Brain nuclei
16%
Density Analysis
16%
Functional Substrate
16%
Cytochrome Oxidase
16%
Alpha Expressions
16%
Extracellular Recording
16%
INIS
rats
100%
ganglions
100%
nuclei
100%
nervous system diseases
100%
levels
27%
surgery
27%
therapy
18%
brain
18%
interventions
18%
neurons
18%
cytochrome oxidase
18%
patients
9%
control
9%
symptoms
9%
receptors
9%
comparative evaluations
9%
stimulation
9%
motors
9%
units
9%
losses
9%
mitochondria
9%
mapping
9%
substrates
9%
machinery
9%
transcription
9%
optical density
9%
Neuroscience
Basal Ganglia
100%
Huntington's Disease
100%
Subthalamic Nucleus
83%
Globus pallidus
66%
Neuronal Activity
33%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
33%
Striatum
33%
Cytochrome C Oxidase
33%
Electrical Brain Stimulation
16%
Immunohistochemistry
16%
Histochemistry
16%
Substantia nigra
16%
Peroxisome Proliferator-Activated Receptor Gamma
16%
Single-Unit Recording
16%
Neurobiology
16%